SCHEMBL12348

SCHEMBL12348

Cc1cc2cc(O)ccc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.59
KEAP1 Q14145 1/20 0.59
FLT3 P36888 6/20 0.55
PDGFRB P09619 3/20 0.55
KIT P10721 2/20 0.55
ABL1 P00519 1/20 0.55
BCR P11274 1/20 0.55
AXL P30530 1/20 0.55
SMAD3 P84022 1/20 0.53
CA2 P00918 1/20 0.50
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
PDGFRA P16234 1/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
RAD51 Q06609 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL28393975 0.98 CYP2A6 (0.57) CYP2A6KEAP1FLT3PDGFRBKIT
2-Chlorophenol SCHEMBL18151937 0.85 ALDH1A1 (0.47) CYP2A6KEAP1FLT3PDGFRBKIT
SCHEMBL27765605 0.84 PTGS2 (0.59) CYP2A6KEAP1FLT3AXLMAPT
SCHEMBL93623 0.83 CA2 (0.50) CYP2A6KEAP1FLT3AXLCA2
SCHEMBL30648021 0.83 CA2 (0.50) CYP2A6KEAP1FLT3AXLCA2
SCHEMBL18152579 0.81 FLT3 (0.47) CYP2A6KEAP1FLT3PDGFRBKIT
SCHEMBL12025195 0.78 FLT3 (0.50) FLT3PDGFRBKITABL1BCR
SCHEMBL2454392 0.77 FLT3 (0.59) FLT3PDGFRBKITABL1BCR
SCHEMBL75581 0.77 CYP2A6 (0.63) CYP2A6KEAP1FLT3PDGFRBAXL
SCHEMBL29727931 0.77 CYP2A6 (0.63) CYP2A6KEAP1FLT3PDGFRBAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118421331-A Aging-resistant holographic polymer dispersed liquid crystal composition, grating device and preparation method 尼卡光学(天津)有限公司 2024-08-02 CN claimed
CN-118221577-A 2-Phenoxyquinoline derivative, and preparation method and application thereof 湖南中医药大学 2024-06-21 CN claimed
CN-112098171-B Preparation method of urine chemical analysis quality control product 郑州标源生物科技有限公司 2023-12-22 CN claimed
CN-116429526-A Urine chemical analysis quality control product and preparation method thereof 上海柏合生物技术有限公司 2023-07-14 CN claimed
CN-115572513-A Fulgide photochromic exterior wall coating and preparation method thereof 中机铸材科技(福建)有限公司 2023-01-06 CN claimed
CN-110643032-B Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2022-01-28 CN claimed
CN-112098171-A Preparation method of urine chemical analysis quality control product 郑州标源生物科技有限公司 2020-12-18 CN claimed
CN-112067399-A Preparation method of urine chemical analysis quality control product 郑州安图生物工程股份有限公司 2020-12-11 CN claimed
CN-112067398-A Urine chemical analysis quality control product 郑州安图生物工程股份有限公司 2020-12-11 CN claimed
CN-110643032-A Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2020-01-03 CN claimed
CN-106967213-B Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2019-11-05 CN claimed
CN-106967213-A Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2017-07-21 CN claimed
US-4013404-A Method of dyeing hair with indolines, indoles and indazoles AMERICAN CYANAMID COMPANY (US) 1977-03-22 US claimed
US-20260022125-A1 PYRROLOPYRIDAZINE VEGFR INHIBITORS MERCK SHARP & DOHME LLC (US) 2026-01-22 US disclosed
US-20250263760-A1 MODIFIED BACTERIA FOR PRODUCTION OF NITROAROMATICS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2025-08-21 US disclosed
US-12319946-B2 Methods for producing modified bacteria for production of nitroaromatics UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2025-06-03 US disclosed
WO-2000042045-A2 FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed
US-5468641-A Device for validating urobilinogen test devices BAYER CORPORATION (US) 1995-11-21 US disclosed
EP-0628821-A2 Device for validating urobilinogen test devices Bayer Corporation (US) 1994-12-14 EP disclosed
US-4013404-A Method of dyeing hair with indolines, indoles and indazoles AMERICAN CYANAMID COMPANY (US) 1977-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022125-A1 PYRROLOPYRIDAZINE VEGFR INHIBITORS FLT1, KDR, FLT4 CYP2A6 132/4885KEAP1 4008/4885FLT3 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.